AR
Amartyesh Roy
About Amartyesh Roy
Data last updated:
Amartyesh Roy is a Director at Kcr Medipharma Private Limited (since 2020). The companies operate in E-Commerce and Pharma. Kcr Medipharma Private Limited reported revenue of ₹97,300 (FY 2024). Earlier, Amartyesh Roy was a Director at Bethel Medipharma Private Limited (2020–2026).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 13 Nov 2020 | 2020 | ₹97,300 (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 03 Sep 2020 | 2020 | ₹95.6 Lakh (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Amartyesh Roy
| Name | DIN | Company | Designation |
|---|---|---|---|
| Himangshu Roy | 06569502 | Kcr Medipharma Private Limited | Director |
| Prabuddha Pal | 08942735 | Kcr Medipharma Private Limited | Director |
| Shikha Roy | 06532075 | Kcr Medipharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Amartyesh Roy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amartyesh Roy
Amartyesh Roy currently holds 1 directorship: Kcr Medipharma Private Limited (Director, since 13 Nov 2020, revenue ₹97,300 (FY 2024)).
Amartyesh Roy was first appointed on 03 Sep 2020 as Director at Bethel Medipharma Private Limited.
Amartyesh Roy held 1 earlier board appointment: Bethel Medipharma Private Limited (Director, 03 Sep 2020 to 05 Jan 2026).
The current boards of Amartyesh Roy's companies include Himangshu Roy (Kcr Medipharma Private Limited), Prabuddha Pal (Kcr Medipharma Private Limited), Shikha Roy (Kcr Medipharma Private Limited).